Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.

Beguin, Yves; Benoit, Yves; Crokaert, F.; Selleslag, Dominik; Vandercam, B.

doi:10.1179/acb.2002.058

Article (Scientific journals)

Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.

Beguin, Yves; Benoit, Yves; Crokaert, F. et al.

2002 • In Acta Clinica Belgica, 57 (6), p. 309-16

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/21185

DOI
10.1179/acb.2002.058

PubMed
12723248

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

178.pdf

Publisher postprint (368.84 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Anti-Bacterial Agents/administration & dosage; Fever/complications; Home Infusion Therapy; Humans; Infection/complications/drug therapy; Infusions, Intravenous; Neutropenia/complications

Abstract :

[en] Febrile neutropenia requires adequate antibiotic treatment. A subgroup of patients are only at low risk for complications and could be treated at home/as outpatients (OHPAT) after a short initial admission for work up. This position paper by a Belgian panel of experts presents criteria defining low-risk in febrile neutropenia, gives an overview of the existing experience and examines the present obstacles to a more widespread use of OHPAT in this country.

Disciplines :

Hematology

Author, co-author :

Beguin, Yves ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique

Benoit, Yves

Crokaert, F.

Selleslag, Dominik

Vandercam, B.

Language :

English

Title :

Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.

Publication date :

2002

Journal title :

Acta Clinica Belgica

ISSN :

0001-5512

Publisher :

Acta Clinica Belgica, Bruxelles, Belgium

Volume :

Issue :

Pages :

309-16

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 07 September 2009

Statistics

Number of views

116 (2 by ULiège)

Number of downloads

294 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Bodey G et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
Pizzo et al. Fever in the pediatric and young adult patient with cancer, a prospective study of 1001 episodes. Medicine 1982; 61:153-65.
Pizzo P. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328:1323-32.
Rucker R, Harrison G. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974; 54:358-60.
Antoniskis et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 1978; 128:203-6.
Tice AD. Preface to outpatient parenteral antimicrobial therapy. Infect Dis Clin North Am 1998; 12:xi-xii.
Francioli P et al. Outpatient treatment of infective endocarditis. Clin Microbiol Infect 1998; 4 (Suppl. 3):47-55.
Rhem SJ. Outpatient intravenous antibiotic therapy for endocarditis. Infect Dis Clin North Am 1998; 12:879-901.
Graninger W et al. Management of serious staphylococcal infections in the outpatient setting. Drugs 1997; 54 (Suppl. 6):21-6
Levy J. et al. Treatment of bone and joint infections: recommendations of a Belgian panel. Acta Orthop Belg 2000; 66:127-36.
Brown R. Outpatient parenteral antibiotic therapy in the management of community-acquired lower respiratory infections. Infect Dis Clin North Am 1998; 12:921-34.
Gunner Deery II H. Outpatient parenteral antibiotic therapy for skin and soft-tissue infections. Infect Dis Clin North Am 1998; 12:935-50.
Tice D, Strait K, Ramey R, Hoaglund P. Outpatient parenteral antimicrobial therapy for central nervous system infections. Clin Infect Dis 1999; 29:1394-99.
Lutz B, Reed Pitre B, Joan Landry R. Practical considerations of outpatient infusion therapy in the HIV arena. Infect Dis Clin North Am 1998; 12:951-61.
Kern WV, Cometta A, de Bock R, Langenaeken J, Paesmans M, Gaya H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341:312-8.
Freifeld A, Marchigiani D, Walsh T, et al. A double-blind comparison of empiric oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341:305-11.
Talcott J, Whalen A, Clark J, Rieker P, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994; 12:107-14.
Rolston K. Outpatient management of fever in neutropenic patients. Current Opinion Inf Dis 1996; 9:407-10.
Rolston K. New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Inf Dis 1999; 29:515-21.
Ball L, Siddal S, van Saenen H. Teicoplanin in home therapy of the terminally ill child. Eur J Haematol 1993; 51(Suppl.54):14-7.
Malik I, Khan W, Karim M. Self-administered antibiotic therapy for chemotherapy-induced low-risk febrile neutropenia in patients with non-hematologic neoplasms. Clin Infect Dis 1994; 19:522-7.
Malik I et al. Feasibility of outpatient management of fever in cancer patients with low risk neutropenia: results of a prospective randomized trial. Am J Med 1995; 98:224-31.
Delporte J. Aspects pharmaco-économiques de l'antibiothérapie à l'hôpital. Rev Med Liège 1998;53:279-84.
Newland A, Ketley N. Non-inpatient parenteral antibiotic therapy in febrile adults. Eur J Haematol 1998; 60(Suppl 62):6-10.
Parker et al. Evaluation of the impact of non-inpatient IV antibiotic treatment for acute infections on the hospital, primary care services
Williams D. Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks? Drug Safety 1996; 1:1-7.
Martone W et al. Incidence and nature of endemic and epidemic nosocomial infections. In Bennett & Brachman, Eds: Hospital Infections, ed. 3, Boston, Little Brown, 1992: pp577-96.
Vinen J. Intravenous antibiotic treatment outside the hospital: safety and health economic aspects. Rev Contemp Pharmacother 1995; 6:435-45.
Eron L. Intravenous antibiotic administration in outpatient settings. Infect Dis 1984; 14:4-11.
Hoffman-Terry M. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999; 106:44-9.
Freifeld A, Pizzo P. The outpatient management of febrile neutropenia in cancer patients. Oncology 1996; 10:599-612.
Talcott J et al. The medical course of cancer patients with fever and neutropenia. Arch Intern Med 1988; 148:2581-88.
Talcott J. Outpatient management of febrile neutropenia: should we change the standard of care? The Oncologist 1997; 2:365-73.
Davis D, Raebel M. Ambulatory management of chemotherapy-induced fever and neutropenia in adult cancer patients. Ann Pharmacother 1998; 32:1317-23.
Hughes W et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 2002; 34:730-51.
Klastersky J et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18:3038-51.
Klaassen RJ et al. "Low-risk" prediction role for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000; 18:1012-9.
Herrmann R, Trent M, Cooney J, Cannell P. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 1999, 24:1213-7.
The EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteremia in granulocytopenic cancer patients. Eur J Cancer 1990; 26:569-74.
Andes D, Craig W. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. Infect Dis Clin North Am 1998; 12:849-60.
Gilbert DN, Dworkin RJ, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997; 337:829-38.
Ozer H et al. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines for the American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 2000; 18:3558-85.
Nathwani D, Zambrowski JJ. Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy. Clin Microbiol Infect 2000; 6:464-76.
Williams DN et al. Practice guidelines for community-based parenteral anti-infective therapy. Clin Infect Dis 1997; 25:787-801.
van den Broek, P et al. Thuisbehandeling met intraveneuze antimicrobiële middelen: een beproefde werkwijze. ITS 1995, Nijmegen.
Haerkens H et al. Intraveneuze toediening van antimicrobiële geneesmiddelen thuis. Een vergelijking met ziekenhuisbehandeling. TNO Preventie en Gezondheid 1997, Leiden.
Quak et al. Richtlijnen voor intraveneuze toediening van antimicrobiële geneesmiddelen thuis. TNO Preventie en Gezondheid 1997, Leiden.